Evidence map›Paper›PMID 41889445›Full record

ArticleInfectious Disease Modelling2026

Modeling the Impact of Malaria Chemoprevention with sulphadoxine-pyrimethamine on the spread of

Nicholaus Mziray, Lucy C Okell, Samson Kiware, Gina Cuomo-Dannenburg, Neterindwa Ainea, Deus S Ishengoma, Nkuba Nyerere

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infectious Disease Modelling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nicholaus MzirayIfakara Health Institute, Environmental Health, and Ecological Sciences Department, P.O. Box 78373, Kiko Avenue, Mikocheni, Dar es Salaam, the United Republic of Tanzania.
Lucy C OkellMRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, UK.
Samson KiwareIfakara Health Institute, Environmental Health, and Ecological Sciences Department, P.O. Box 78373, Kiko Avenue, Mikocheni, Dar es Salaam, the United Republic of Tanzania.
Gina Cuomo-DannenburgMRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, UK.
Neterindwa AineaDepartment of Mathematics and Statistics, Sokoine University of Agriculture, P.O.Box 3000, Morogoro, the United Republic of Tanzania.
Deus S IshengomaIfakara Health Institute, Environmental Health, and Ecological Sciences Department, P.O. Box 78373, Kiko Avenue, Mikocheni, Dar es Salaam, the United Republic of Tanzania.
Nkuba NyerereDepartment of Mathematics and Statistics, Sokoine University of Agriculture, P.O.Box 3000, Morogoro, the United Republic of Tanzania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sulfadoxine-pyrimethamine (SP) is a key antimalarial used in chemoprevention strategies, including intermittent preventive treatment in pregnancy (IPTp); intermittent preventive treatment in infants (IPTi); seasonal malaria chemoprevention (SMC); and mass drug administration (MDA). Malaria chemoprevention using sulfadoxine-pyrimethamine (SP) has shown a positive impact in preventing millions of malaria cases in the setting were it has widely been implemented. However, the spread of SP resistance in

Indexed as

MalariaMalaria chemopreventionMathematical modelingResistant mutationsSulphadoxine-pyrimethamine

Identifiers

PMID41889445
PMCPMC13015634

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.